Clinical Trial

Skin Reactions Related to Thoracic Implantable Chamber Dressings

Study acronym: KPAREAC
Recruiting
View on ClinicalTrials.gov →
Summary
Prospective, multicenter cohort of 500 patients newly treated with systemic chemotherapy with CCI. The main objective of this study is to measure the incidence of skin reactions related to thoracic implantable chamber dressings.
Trial Details
NCT Number NCT07158879
Lead Sponsor Institut Curie
Conditions Skin Diseases
Enrollment 500 participants
Start Date 2025-06-10
Primary Completion 2026-12-10 (estimated)
Study Completion 2026-12-10 (estimated)
Updated on ClinicalTrials.gov 2025-09-08